David R. Epstein, Director at Evelo Biosciences, Inc. (EVLO), bought 10,000 shares at $4.47 ($44K) on 2020-08-31, disclosed to the SEC on 2020-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.34 | 1,000 | $4K | 9.8% |
| 2 | $4.40 | 3,248 | $14K | 32.2% |
| 3 | $4.46 | 2,752 | $12K | 27.6% |
| 4 | $4.47 | 1,000 | $4K | 10.1% |
| 5 | $4.48 | 1,000 | $4K | 10.1% |
| 6 | $4.58 | 1,000 |
| $5K |
| 10.3% |
| Total | $4.44 avg | 10,000 | $44K | 100% |
| Filing → |
| TEM | SELL | 2026-06-03 | $12K | — | Filing → |
| TEM | SELL | 2026-03-04 | $13K | — | Filing → |
| TEM | SELL | 2026-02-04 | $22K | — | Filing → |